Abbott Laboratories - Enterprise Value To Ebitda Ratio

Abbott Laboratories's Fiscal Year is From January To December.

The item "Enterprise-Value-To-Ebitda-Ratio" stands at 20.15 as of 09/30/2025.

As of the end of Abbott Laboratories's third quarter, the item "Enterprise Value To Ebitda Ratio" stands at 20.15. This represents a decrease of -1.80 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.45 percent compared to the value the year prior.
The 1 year change in percent is 8.45.
The 3 year change in percent is 55.30.

The Serie's long term average value is 17.52. It's latest available value, on 09/30/2025, is 14.98 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +55.30%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -2.93%.